Denvax Cellular Therapies Private Limited - Company Profile

It is a packaging private limited company based in New Delhi, Delhi, India, established in 2009.
2009 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Denvax Cellular Therapies Private Limited

Denvax Cellular Therapies Private Limited, a active private limited company, was established on 31 July 2009 in New Delhi, Delhi, India. Engaging in paper within the hospital and medical care sector, it holds CIN: U85191DL2009PTC192776. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.10 Cr and a paid-up capital of ₹1.10 Cr.

It upholds a compliant status. Its leadership includes Anita Mehra (Director), Sanjiv Kumar Jain (Director), Anju Sanjiv Kumar Jain (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Kh.N.-153-B, Western Avenue, Sainik Farm Near Bses Transformer, New Delhi, Delhi, 110062.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85191DL2009PTC192776

  • Registration Number

    192776

  • Incorporation Date

    31 July 2009

  • Authorized Capital

    ₹1.10 Cr

  • Paid-Up Capital

    ₹1.10 Cr

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.10 Cr
  • Paid Up Capital ₹ 1.10 Cr
  • Company Age 16 Year, 7 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth **** %
  • Profit Growth **** -16.35%
  • Ebitda **** -16.67%
  • Net Worth 3.86%
  • Total Assets **** %
Company report

Denvax Cellular Therapies Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Denvax Cellular Therapies Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Denvax Cellular Therapies Private Limited?
Current Directors
Name Designation Appointment Date Status
Anita Mehra Director 31 Jul 2009 Current
Sanjiv Kumar Jain Director 31 Jul 2009 Current
Anju Sanjiv Kumar Jain Director 31 Jul 2009 Current
Arun Mehra Director 31 Jul 2009 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Denvax Cellular Therapies.

Denvax Cellular Therapies Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 16.35% decrease in profit. The company's net worth moved up by a moderate rise of 3.86%.

Denvax Cellular Therapies revenue growth over time
Denvax Cellular Therapies profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
 -16.35%
*******
*******
*******
*******
Net Worth
*******
 3.86%
*******
*******
*******
*******
EBITDA
*******
 -16.67%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Denvax Cellular Therapies?

In 2023, Denvax Cellular Therapies had a public holding of 2.36%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Denvax Cellular Therapies?

Unlock and access historical data on people associated with Denvax Cellular Therapies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Denvax Cellular Therapies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Denvax Cellular Therapies's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Denvax Cellular Therapies
Recent Activity within the Organization
  • Annual General Meeting

    The activity Denvax Cellular Therapies Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.

  • Balance Sheet

    Denvax Cellular Therapies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.

  • Director Appointment

    The activity Anita Mehra was appointed as a Director was appointed as a Director on 31 Jul 2009 & has been associated with this company since 16 years 7 months . was completed.

  • Director Appointment

    The activity Sanjiv Kumar Jain was appointed as a Director was appointed as a Director on 31 Jul 2009 & has been associated with this company since 16 years 7 months . was completed.

  • Director Appointment

    Progress on Anju Sanjiv Kumar Jain was appointed as a Director was appointed as a Director on 31 Jul 2009 & has been associated with this company since 16 years 7 months . was documented.

  • Director Appointment

    Arun Mehra was appointed as a Director was appointed as a Director on 31 Jul 2009 & has been associated with this company since 16 years 7 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Denvax Cellular Therapies Private Limited?

The CIN of Denvax Cellular Therapies Private Limited is U85191DL2009PTC192776.

Where is Denvax Cellular Therapies Private Limited headquartered?

Denvax Cellular Therapies Private Limited is headquartered at Kh.N.-153-B, Western Avenue, Sainik Farm Near Bses Transformer, New Delhi, Delhi, 110062.

When was Denvax Cellular Therapies Private Limited incorporated?

Denvax Cellular Therapies Private Limited was incorporated on 31 July 2009.

Who are the current directors of Denvax Cellular Therapies Private Limited?

The current directors of Denvax Cellular Therapies Private Limited are

What is the primary industry of Denvax Cellular Therapies Private Limited?

The primary industry of Denvax Cellular Therapies Private Limited is Hospital And Medical Care.

Is Denvax Cellular Therapies Private Limited a listed company?

Denvax Cellular Therapies Private Limited is unlisted.

What is the capital structure of Denvax Cellular Therapies Private Limited?

The authorized capital of Denvax Cellular Therapies Private Limited is ₹1.10 Cr, and the paid-up capital is ₹1.10 Cr.

What is the compliance status of Denvax Cellular Therapies Private Limited?

The compliance status of Denvax Cellular Therapies Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available